---
Paclitaxel: A Potent Anti-Cancer Agent withEvolving Clinical Potential
Blue Eyes Biotech Co., Ltd., a trustedsupplier of high-purity plant extracts, explores the science behindpaclitaxel—one of nature’s most effective anti-cancer compounds. Derived fromthe Taxus (yew) tree, paclitaxel remains a cornerstone in oncology drugdevelopment, with expanding applications in breast, ovarian, and lung cancertherapies.
HowPaclitaxel Works Against Cancer
Paclitaxel’s unique mechanism of actiondisrupts microtubule dynamics, preventing cancer cells from dividing. Keyeffects include:
- Stabilizing microtubules, blockingmitosis (cell division)
- Inducing apoptosis (programmed celldeath) in malignant cells
- Enhancing radiation sensitivity incombination therapies
2024Clinical Applications Update
1. First-Line Chemotherapy
-Breast & ovarian cancer: Often combined with carboplatin ordoxorubicin
-Non-small cell lung cancer (NSCLC): Used in albumin-bound nanoparticle form(nab-paclitaxel)
2. Emerging Research Areas
-Pancreatic & prostate cancer trials
-Targeted drug delivery systems (e.g., antibody-conjugated paclitaxel)
3. Adjuvant Therapy
-Post-surgical applications to prevent recurrence
Sourcing High-Quality Paclitaxel
For pharmaceutical manufacturers, ensuringGMP-compliant paclitaxel is critical. Blue Eyes Biotech provides:
- 98%+ HPLC-verified paclitaxel(semi-synthetic or plant-derived)
- Full regulatory documentation (FDA/EMAcompliance, CITES certification)
- Bulk & research quantities (grams tokilograms)
Partner with a Reliable PaclitaxelSupplier
Email: [email protected]
Website: www.blueeyes-bio.com